{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:10:51Z","timestamp":1791461451598,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,16]]},"DOI":"10.7759\/cureus.99366","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:01:46Z","timestamp":1765890106000},"source":"Crossref","is-referenced-by-count":1,"title":["Seropositive Myasthenia Gravis Triggered by Lyme Disease: A Case Study of Molecular Mimicry"],"prefix":"10.7759","author":[{"given":"Sahil","family":"Sardana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"MacGavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Abdullah","family":"Shakeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Piccinnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taranjit Singh","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review","volume":"315","author":"Sanchez E","year":"2016","unstructured":"Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016, 315:1767-77. 10.1001\/jama.2016.2884","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses, United States, 2010-2018","volume":"27","author":"Kugeler KJ","year":"2021","unstructured":"Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF. Estimating the frequency of Lyme disease diagnoses, United States, 2010-2018. Emerg Infect Dis. 2021, 27:616-9. 10.3201\/eid2702.202731","journal-title":"Emerg Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme disease - United States, 2008-2015","volume":"66","author":"Schwartz AM","year":"2017","unstructured":"Schwartz AM, Hinckley AF, Mead PS, Hook SA, Kugeler KJ. Surveillance for Lyme disease - United States, 2008-2015. MMWR Surveill Summ. 2017, 66:1-12. 10.15585\/mmwr.ss6622a1","journal-title":"MMWR Surveill Summ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis-epidemiology, diagnosis and management","volume":"11","author":"Koedel U","year":"2015","unstructured":"Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol. 2015, 11:446-56. 10.1038\/nrneurol.2015.121","journal-title":"Nat Rev Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: a clinical-immunological update","volume":"263","author":"Binks S","year":"2016","unstructured":"Binks S, Vincent A, Palace J. Myasthenia gravis: a clinical-immunological update. J Neurol. 2016, 263:826-34. 10.1007\/s00415-015-7963-5","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1339167","article-title":"Epidemiology of myasthenia gravis in the United States","volume":"15","author":"Ye Y","year":"2024","unstructured":"Ye Y, Murdock DJ, Chen C, Liedtke W, Knox CA. Epidemiology of myasthenia gravis in the United States. Front Neurol. 2024, 15:1339167. 10.3389\/fneur.2024.1339167","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(99)00117-2","article-title":"Antigen mimicry in autoimmune disease: can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of myasthenia gravis?","volume":"61","author":"Deitiker P","year":"2000","unstructured":"Deitiker P, Ashizawa T, Atassi MZ. Antigen mimicry in autoimmune disease: can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of myasthenia gravis?. Hum Immunol. 2000, 61:255-65. 10.1016\/S0198-8859(99)00117-2","journal-title":"Hum Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.618021","article-title":"A systematic review of the potential implication of infectious agents in myasthenia gravis","volume":"12","author":"Leopardi V","year":"2021","unstructured":"Leopardi V, Chang YM, Pham A, Luo J, Garden OA. A systematic review of the potential implication of infectious agents in myasthenia gravis. Front Neurol. 2021, 12:618021. 10.3389\/fneur.2021.618021","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00365540600818029","article-title":"Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies","volume":"39","author":"Finsterer J","year":"2007","unstructured":"Finsterer J. Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies. Scand J Infect Dis. 2007, 39:187-90. 10.1080\/00365540600818029","journal-title":"Scand J Infect Dis"},{"key":"ref10","article-title":"Lyme disease and myasthenia gravis","volume":"43","author":"Evlice A","year":"2018","unstructured":"Evlice A, Ko\u00e7 F. Lyme disease and myasthenia gravis. Cukurova Med J. 2018, 43:317-9.","journal-title":"Cukurova Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260608","article-title":"Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue","volume":"26","author":"Aberer E","year":"1989","unstructured":"Aberer E, Brunner C, Suchanek G, Klade H, Barbour A, Stanek G, Lassmann H. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol. 1989, 26:732-7. 10.1002\/ana.410260608","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.10.014","article-title":"Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue","volume":"159","author":"Alaedini A","year":"2005","unstructured":"Alaedini A, Latov N. Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue. J Neuroimmunol. 2005, 159:192-5. 10.1016\/j.jneuroim.2004.10.014","journal-title":"J Neuroimmunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12697","article-title":"Molecular mimicry: an explanation for autoimmune diseases and infertility","volume":"88","author":"Thaper D","year":"2018","unstructured":"Thaper D, Prabha V. Molecular mimicry: an explanation for autoimmune diseases and infertility. Scand J Immunol. 2018, 88:e12697. 10.1111\/sji.12697","journal-title":"Scand J Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200436","article-title":"AChR autoantibody pathogenic properties are heterogeneously distributed and undergo temporal changes among patients with myasthenia gravis","volume":"12","author":"Khani-Habibabadi F","year":"2025","unstructured":"Khani-Habibabadi F, Roy B, Pham MC, Obaid AH, Filipek B, Nowak RJ, O'Connor KC. AChR autoantibody pathogenic properties are heterogeneously distributed and undergo temporal changes among patients with myasthenia gravis. Neurol Neuroimmunol Neuroinflamm. 2025, 12:e200436. 10.1212\/NXI.0000000000200436","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13071","article-title":"Autoantibodies in acquired myasthenia gravis: clinical phenotype and immunological correlation","volume":"139","author":"Nagappa M","year":"2019","unstructured":"Nagappa M, Mahadevan A, Gangadhar Y, et al.. Autoantibodies in acquired myasthenia gravis: clinical phenotype and immunological correlation. Acta Neurol Scand. 2019, 139:428-37. 10.1111\/ane.13071","journal-title":"Acta Neurol Scand"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02493-6","article-title":"Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities","volume":"144","author":"Rose N","year":"2022","unstructured":"Rose N, Holdermann S, Callegari I, et al.. Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities. Acta Neuropathol. 2022, 144:1005-25. 10.1007\/s00401-022-02493-6","journal-title":"Acta Neuropathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1977580","article-title":"Laryngeal myasthenia gravis following influenza vaccination: a case report and literature review","volume":"17","author":"Wang F","year":"2021","unstructured":"Wang F, Xiang T, He L, Wang J. Laryngeal myasthenia gravis following influenza vaccination: a case report and literature review. Hum Vaccin Immunother. 2021, 17:5529-31. 10.1080\/21645515.2021.1977580","journal-title":"Hum Vaccin Immunother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2001.569","article-title":"Myasthenia gravis after hepatitis B vaccine: report of one case","volume":"60","author":"Bahri ME","year":"2001","unstructured":"Bahri ME, Louzir B, Othmani S, Battikh R, Bahri MO. Myasthenia gravis after hepatitis B vaccine: report of one case. Ann Rheum Dis. 2001, 60:A226-7. 10.1136\/annrheumdis-2001.569","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1233-y","article-title":"Myasthenia gravis following human papillomavirus vaccination: a case report","volume":"18","author":"Chung JY","year":"2018","unstructured":"Chung JY, Lee SJ, Shin BS, Kang HG. Myasthenia gravis following human papillomavirus vaccination: a case report. BMC Neurol. 2018, 18:222. 10.1186\/s12883-018-1233-y","journal-title":"BMC Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.09.001","article-title":"SARS-CoV-2 vaccination and new-onset myasthenia gravis: a report of 7 cases and review of the literature","volume":"32","author":"Ramdas S","year":"2022","unstructured":"Ramdas S, Hum RM, Price A, et al.. SARS-CoV-2 vaccination and new-onset myasthenia gravis: a report of 7 cases and review of the literature. Neuromuscul Disord. 2022, 32:785-9. 10.1016\/j.nmd.2022.09.001","journal-title":"Neuromuscul Disord"},{"key":"ref21","unstructured":"Centers for Disease Control and Prevention. Lyme disease. (2022). Accessed. July 16, 2025: https:\/\/www.cdc.gov\/lyme\/index.html."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21924","article-title":"Outcome of plasmapheresis in myasthenia gravis: delayed therapy is not favorable","volume":"43","author":"Mandawat A","year":"2011","unstructured":"Mandawat A, Mandawat A, Kaminski HJ, Shaker ZA, Alawi AA, Alshekhlee A. Outcome of plasmapheresis in myasthenia gravis: delayed therapy is not favorable. Muscle Nerve. 2011, 43:578-84. 10.1002\/mus.21924","journal-title":"Muscle Nerve"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114282","article-title":"Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus","volume":"84","author":"Schwimmbeck PL","year":"1989","unstructured":"Schwimmbeck PL, Dyrberg T, Drachman DB, Oldstone MB. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest. 1989, 84:1174-80. 10.1172\/JCI114282","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008757","article-title":"New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: a case report and literature review","volume":"96","author":"Takizawa T","year":"2017","unstructured":"Takizawa T, Kojima M, Suzuki S, et al.. New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: a case report and literature review. Medicine (Baltimore). 2017, 96:e8757. 10.1097\/MD.0000000000008757","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/442400-seropositive-myasthenia-gravis-triggered-by-lyme-disease-a-case-study-of-molecular-mimicry","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:01:49Z","timestamp":1765890109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/442400-seropositive-myasthenia-gravis-triggered-by-lyme-disease-a-case-study-of-molecular-mimicry"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.99366","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,16]]}}}